Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of TAK-114 in Healthy Men
NCT02286518Phase 1Completed
- Sponsor
- Takeda
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TAK-114 in ulcerative colitis (UC) (14 arms), sponsored by Takeda. Primary endpoint: Number of Participants Reporting One or More Treatment-emergent Adverse Events at Day 20. Started Nov 2014; status: completed.
02
Drugs
TAK-114
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02286518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286518.